STRM — Streamline Health Solutions Income Statement
0.000.00%
Last trade - 00:00
- $18.88m
- $26.12m
- $24.89m
- 37
- 60
- 19
- 33
2019 January 31st | R2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22.4 | 11.9 | 11.3 | 17.4 | 24.9 |
Cost of Revenue | |||||
Gross Profit | 14.2 | 6.5 | 5.66 | 8.8 | 11.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 27.7 | 19.2 | 17.3 | 25.9 | 35.7 |
Operating Profit | -5.3 | -7.35 | -5.95 | -8.48 | -10.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.87 | -7.88 | -6.06 | -6.81 | -11.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.87 | -6.24 | -4.8 | -6.92 | -11.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.87 | -2.86 | 0.296 | -6.54 | -11.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.87 | 2.03 | 0.296 | -6.54 | -11.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.112 | -0.015 | -0.159 | -0.153 | -0.231 |